133 related articles for article (PubMed ID: 9823998)
1. The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications.
Gallant JE; Chaisson RE; Moore RD
Chest; 1998 Nov; 114(5):1258-63. PubMed ID: 9823998
[TBL] [Abstract][Full Text] [Related]
2. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
3. Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia.
Martos A; Podzamczer D; Martinez-Lacasa J; Rufi G; Santin M; Gudiol F
AIDS; 1995 Sep; 9(9):1037-41. PubMed ID: 8527075
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
Briel M; Bucher HC; Boscacci R; Furrer H
Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
[TBL] [Abstract][Full Text] [Related]
5. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution.
Jensen AM; Lundgren JD; Benfield T; Nielsen TL; Vestbo J
Chest; 1995 Aug; 108(2):411-4. PubMed ID: 7634876
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Bozzette SA; Sattler FR; Chiu J; Wu AW; Gluckstein D; Kemper C; Bartok A; Niosi J; Abramson I; Coffman J
N Engl J Med; 1990 Nov; 323(21):1451-7. PubMed ID: 2233917
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia.
Inoue N; Fushimi K
Int J Infect Dis; 2019 Feb; 79():109-115. PubMed ID: 30529109
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.
McKinnell JA; Cannella AP; Kunz DF; Hook EW; Moser SA; Miller LG; Baddley JW; Pappas PG
Transpl Infect Dis; 2012 Oct; 14(5):510-8. PubMed ID: 22548840
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia.
Sleasman JW; Hemenway C; Klein AS; Barrett DJ
Am J Dis Child; 1993 Jan; 147(1):30-4. PubMed ID: 8093422
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
Dore GJ; Hoy JF; Mallal SA; Li Y; Mijch AM; French MA; Cooper DA; Kaldor JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):39-43. PubMed ID: 9377123
[TBL] [Abstract][Full Text] [Related]
11. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
12. Decreasing frequency but worsening mortality of acute respiratory failure secondary to AIDS-related Pneumocystis carinii pneumonia.
Hawley PH; Ronco JJ; Guillemi SA; Quieffin J; Russell JA; Lawson LM; Schechter MT; Montaner JS
Chest; 1994 Nov; 106(5):1456-9. PubMed ID: 7956401
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials.
Briel M; Boscacci R; Furrer H; Bucher HC
BMC Infect Dis; 2005 Nov; 5():101. PubMed ID: 16271157
[TBL] [Abstract][Full Text] [Related]
14. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia.
Pareja JG; Garland R; Koziel H
Chest; 1998 May; 113(5):1215-24. PubMed ID: 9596297
[TBL] [Abstract][Full Text] [Related]
15. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia.
Caumes E; Roudier C; Rogeaux O; Bricaire F; Gentilini M
Clin Infect Dis; 1994 Mar; 18(3):319-23. PubMed ID: 8011811
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia.
Pottratz ST
Chest; 1998 Nov; 114(5):1230-1. PubMed ID: 9823990
[No Abstract] [Full Text] [Related]
17. A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease.
Shibata S; Nishijima T; Aoki T; Tanabe Y; Teruya K; Kikuchi Y; Kikuchi T; Oka S; Gatanaga H
PLoS One; 2015; 10(9):e0138926. PubMed ID: 26393804
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial.
Gagnon S; Boota AM; Fischl MA; Baier H; Kirksey OW; La Voie L
N Engl J Med; 1990 Nov; 323(21):1444-50. PubMed ID: 2233916
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia.
Benfield TL; Helweg-Larsen J; Bang D; Junge J; Lundgren JD
Chest; 2001 Mar; 119(3):844-51. PubMed ID: 11243967
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome.
Walmsley S; Levinton C; Brunton J; Muradali D; Rappaport D; Bast M; Spence D; Salit I
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):348-57. PubMed ID: 7882099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
